As many target genes of miR-34a, including sirt1 [108] and survivin [109], have been shown to promote cancer progression and/or were associated with poor patient prognosis, miR-34a is frequently referred to as a tumour suppressor [62]. This evidence concerns the gene BIRC5 and cancer.